Dermoplast

Dermoplast® develops specialized first aid and pain relief products catering primarily to new mothers, while also serving a broader audience. Their offerings include sprays for pain relief, skin irritations, and first aid solutions. Dermoplast® is known for producing first aid and pain relief products. The company was acquired in 1996 by Medtech Holdings Inc.

, which is part of the TSG Consumer Partners portfolio, from American Home Products Corp. The acquisition terms were not disclosed. Dermoplast® specializes in producing a range of first aid and pain relief products designed primarily for new mothers, though they are suitable for a broader customer base. Their flagship product, the Dermoplast® Postpartum Spray, offers fast, cooling relief for a variety of minor ailments such as sunburns, insect bites, minor cuts, and skin irritations.

This product is particularly targeted towards new moms experiencing discomfort in sensitive areas following childbirth. The company also offers a variety of other products, including Pain, Burn & Itch Spray, First Aid Antibacterial Spray, Kids Sting-Free Spray, and On-the-Go Wound Wipes. Dermoplast® products are distributed primarily in the United States and are aimed at retail outlets, pharmacies, and hospitals, serving clients ranging from individual consumers to healthcare professionals. The revenue model for Dermoplast® encompasses direct-to-consumer sales as well as partnerships with retailers and healthcare providers.

The company engages in transactions with various retail chains and pharmacies, supplying them with their product lines, which include the Dermoplast® Postpartum Spray and other first aid solutions. While specific pricing details are not disclosed, the products are positioned within the first aid category, appealing to a wide consumer market. Additionally, Dermoplast® maintains a reputation for high-quality products backed by over 50 years of trust and innovation in the healthcare space, which supports repeat business and brand loyalty among customers. Following their acquisition in 1996, Dermoplast® has focused on enhancing its product lines.

They are planning to introduce new products targeting various first aid needs by the end of 2024. The company aims to expand its distribution network into additional regions within North America and Europe over the next few years. The funding from their last deal will support product development and market expansion initiatives.